Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05743517 · ClinicalTrials.gov registry record · NA
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
A NA study of Endometrial Cancer and Cervical Cancer, sponsored by Northwestern University.
- Recruiting
- Registry status
- NA
- Development phase
- 192
- Enrollment target
- 1
- Study location
NCT05743517: Recruiting NA study of Endometrial Cancer and Cervical Cancer, sponsored by Northwestern University.
NCT05743517 is a NA study of Endometrial Cancer and Cervical Cancer that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 192 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05743517, a NA study of Endometrial Cancer and Cervical Cancer, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- NA
- Development phase
- 192 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary purpose of the study is to determine which of four components (symptom-burden tailored app, exercise partner, oncology provider engagement, coaching) added to a core intervention of a wearable activity tracker and commercially available app, will improve physical activity. The findings will generate meaningful knowledge about how to best increase physical activity in older gynecologic cancer patients receiving systemic cancer therapies to improve quality of life and cancer-specific survival.
Primary Outcome
The primary outcome of average steps per day over a 7 day period will be measured with Actigraph. Patients will wear an accelerometer for 7 days prior to study intervention, 7 days at the conclusion of the 12-week Fit4Treatment intervention, and 7 days at the conclusion of the 12 week follow up period.
Conditions Studied
Interventions
- BEHAVIORAL Fit4Treatment
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2023-09-15 |
| Est. Completion | 2029-08-01 |
| Phase | NA |
What NCT05743517 shows while recruiting
NCT05743517 is an interventional study that assigns participants to a tested intervention. The registered 192 participants enrollment target is mid-sized for trials with a published cap, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (63% lower).
The record links to 7 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which Fit4Treatment is the first listed.
NCT05743517 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05743517 about?
NCT05743517 is a clinical study titled "Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)". The primary purpose of the study is to determine which of four components (symptom-burden tailored app, exercise partner, oncology provider engagement, coaching) added to a core intervention of a wearable activity tracker and commercially available app, will improve physical activity. The findings w...
What is the current status of trial NCT05743517?
This trial is currently recruiting. It is a NA study. The enrollment target is 192 participants. The study started on 2023-09-15. Estimated completion is 2029-08-01.
What conditions does trial NCT05743517 study?
This clinical trial studies the following conditions: Endometrial Cancer, Cervical Cancer, Uterine Cancer, Vulvar Cancer, Vaginal Cancer.
What interventions are being tested in trial NCT05743517?
The interventions under investigation include: Fit4Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT05743517?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05743517 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05743517's enrollment target sits among peer trials
192 72nd of 181 higher than 110 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
-
Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01492972 · 192 participants · Phase 3
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- NCT01973881 · 192 participants
Quantitative MRI for Myelofibrosis
- NCT02535702 · 192 participants · NA
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
- NCT03622359 · 192 participants · NA
Radiotracer-Based Perfusion Imaging of Patients With Peripheral Arterial Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI